Article Contents ::
- 1 The Brand Name ACETEC Has Generic Salt :: ACITRETIN
- 2 ACETEC Is From Company Priced :: Rs. 341
- 3 ACETEC have ACITRETIN is comes under Sub class Anti Psoriatic Drugs of Main Class Skin
- 4 Main Medicine Class:: Skin Sub Medicine Class :: Anti Psoriatic Drugs
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name ACETEC Has Generic Salt :: ACITRETIN
ACETEC Is From Company Priced :: Rs. 341
ACETEC have ACITRETIN is comes under Sub class Anti Psoriatic Drugs of Main Class Skin
Main Medicine Class:: Skin Sub Medicine Class :: Anti Psoriatic Drugs
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| ACITRETIN | CAP | Rs. 341 | 10 |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 10 |
| ACETEC | 10MG | 10 | Rs. 341 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From :: ACETEC | ACITRETIN | Skin | Anti Psoriatic Drugs |
Indications for Drugs ::
Lichen planus, Psoriasis, Congenital icthyosis, Darier’s disease
Drug Dose ::
Oral Darier’s disease Adult: Initially, 10 mg daily for 2-4 wk. Max: 50 mg/day. Congenital icthyosis Adult: Initially, 25-30 mg daily for 2-4 wk before dose adjustments are done. Usual range: 25-50 mg daily for further 6-8 wk. Max: 75 mg daily for short periods. Severe psoriasis Adult: Initially, 25-30 mg daily for 2-4 wk before dose adjustments are done. Usual range: 25-50 mg daily for further 6-8 wk. Max: 75 mg daily for short periods. Severe lichen planus Adult: Initially, 25-30 mg daily for 2-4 wk before dose adjustments are done. Usual range: 25-50 mg daily for further 6-8 wk. Max: 75 mg daily for short periods. Child: 500 mcg/kg/day. Max: 35 mg daily.
Contraindication ::
Pregnancy (before the start, during and at least 2-3 yr after cessation of therapy), lactation. Hepatic and renal impairment. Hyperlipidaemia.
Drug Precautions ::
Female patients to avoid alcohol during and 2 mth after treatment. Avoid blood donation during therapy or at least 1-3 yr after stopping therapy. Children. Radiographic treatment for prolonged therapy. Therapy should not last >6 mth. Monitor plasma lipid and glucose levels (especially diabetics) regularly. Monitor LFTs.
Drug Side Effects ::
Dryness of mucous membranes and skin; conjunctivitis, dry sore mouth; ophth disturbances; raised lipid level, pancreatitis; sticky skin, dermatitis. Severe headache; GI disturbances; dermatologic reactions, oedema, paronychia, granulomatous lesions, bullous eruptions; reversible hair thinning and alopoecia; CNS disturbances; sweating; taste disturbance, gingivitis; benign intracranial hypertension; photosensitivity; skeletal hyperostosis; extraosseous calcification; premature epiphyseal closure in child. Potentially Fatal: Phototoxicity, jaundice, hepatitis and hepatotoxity.
Pregnancy category ::
5
Drug Mode of Action ::
Acitretin is an active metabolite of etretinate but its mechanism of action is unknown.
Drug Interactions ::
Concomitant use with keratolytics or high dose vitamin A. Reduces anticoagulant effect of coumarins e.g. warfarin. Concomitant use of microdised progestin oral contraceptives. Concomitant use of methotrexate can potentiate hepatotoxicty. Concomitant use with tetracycline.
